Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Antimicrobial Resistance

    Tru-D SmartUVC Locks in Disinfection Robot Agreement with HealthTrust

    By Global Biodefense StaffMarch 23, 2015
    Share
    Facebook LinkedIn Reddit Email

    Tru-D SmartUVC LLC has announced an agreement with HealthTrust, which serves 1,350 acute care facilities and members in more than 15,000 locations.

    Tru-D SmartUVC is a germ-eliminating UV disinfection robot used to kill germs and pathogens that plague health care environments. The device measures UVC dose and calculates the proper time needed to thoroughly deliver a measured dose of UV light from a single placement in the room.

    The new agreement will allow Tru-D SmartUVC’s automated disinfection robot to be purchased and utilized by hospitals in the HealthTrust members that are committed to taking their infection prevention efforts to the next level.

    “Hospitals are increasingly recognizing the need for an advanced and integrated approach to improving patient outcomes on several levels,” said Chuck Dunn, president and chief executive officer of Tru-D Smart UVC LLC. “Antibiotic resistant bacteria and HAIs are a challenge that cost health care facilities billions of dollars every year. By integrating advanced technology that has been proven as a solution time and time again, hospitals are not only saving money, but they are also protecting patients and staff from acquiring potentially deadly illnesses.”

    HealthTrust members include acute, ambulatory surgery centers, physician practices, long-term care facilities and alternate care sites. With an established reputation in acute care facilities across the United States, Tru-D SmartUVC is now expanding access to other health care providers and facilities in the industry through this contractual partnership.

    Third Party comparisons to pulsed xenon methods conclude Tru-D SmartUVC is six times more effective eliminating Clostridium difficile spores, seven times more effective removing vancomycin-resistant Enterococcus (VRE), and twice as effective against methicillin-resistant Staphylococcus aureus (MRSA).

    Hundreds of Tru-Ds have been deployed to disinfect hospitals across the U.S., Canada, Europe and Africa, including the National Institutes of Health Clinical Center in Bethesda, Maryland; Nottingham University Hospitals NHS Trust’s QMC campus in Nottingham, England; and Ebola Treatment Units at ELWA Hospital and Island Hospital in Monrovia, Liberia.

    Source: Tru-D SmartUVC press release, adapted.

    C. diff MRSA
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleBiodefense Headlines – Mar 22, 2015
    Next Article BARDA Seeks 3D Visualization Hub for Emergency Response

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    New Self-Decontaminating Fabric Burns Viruses, Safe for Skin

    September 14, 2023

    A New Way to Create Germ-Killing Light

    September 11, 2023

    Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus

    August 24, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.